Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, ...

Nick Woltemade’s barren run in front of goal stretched to seven games in all competitions after Newcastle United’s ...

UK-based AI infrastructure and solutions provider, Sovereign AI (S-AI) has selected Accenture (NYSE: ACN), and Palantir ...

Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...

As part of its renewed effort to get more creators posting long-form content to the app, X has announced that it will pay out ...

Young athletes in northern Ukraine spend their days cross-country skiing through a scorched forest, focused on their form — ...

Rather than stand pat or rebuild, the New York Rangers announced they plan to initiate a retool in a letter general manager Chris Drury penned Friday to the team's aggrieved ...

Young athletes in northern Ukraine spend their days cross-country skiing through a scorched forest, focused on their form — ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...